Skip to main content
. 2017 Apr 10;8:135. doi: 10.3389/fneur.2017.00135

Table 1.

Demographic and clinical data of the training and test cohorts.

PD Older adults
Training cohort
N (females) 5 (3) 1 (1)
Age (years) 71 (4) 51
UPDRS III (0–132) 23 (10) 3 (0)
H&Y (0–5) 2 (1) 0 (0)
LED (mg) 713 (640) (0)
Test cohort
N (females) 20 (10) 13 (6)
Age (years) 66 (9) 60 (10)
UPDRS III (0–132) 32 (12) 2 (4)
H&Y (0–5) 3 (1) 0 (0)
LED (mg) 839 (622) 0 (0)

Data are shown as mean ± SD, except gender and observed turns.

H&Y, Hoehn & Yahr; LED, Levodopa equivalent dose; PD, Parkinson’s disease; UPDRS, Unified Parkinson’s Disease Rating Scale III, motor part of the revised Unified PD Rating scale.

HHS Vulnerability Disclosure